ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
FDA Grants Orphan Drug Designation for Shylicine? americanpharmaceuticalreview
April 07, 2021Vanessa Biotech, the Hamden, Conn.-based global biomedical company dedicated to making an impact on healthcare markets, has been granted orphan drug designation by the U.S. Food and Drug Administration (FDA) for the drug Shylicine? (patent pending). -
Shylicine Granted Orphan Designation americanpharmaceuticalreview
October 29, 2020Vanessa Research (VR) has been granted positive orphan drug opinion by the European Medicines Agency (EMA) for their drug Shylicine? (patent pending).
Pharma Sources Insight January 2025
